Data Insights
Artificial Intelligence (7)
Big Data (5)
Biosimilars (1)
Blockchain (2)
Cell & Gene Therapy (1)
Cloud (4)
Corporate Governance (4)
Covid-19 (4)
Cybersecurity (5)
Digitalization (2)
Easy & Affordable (1)
Electronic Medical Record (EMR) Systems (1)
Environmental Sustainability (5)
Future of Work (3)
Genomics (1)
Health & Wellness (1)
Immuno-oncology (7)
Internet of Things (3)
Microbiome (2)
Mobile Health (1)
Nanomedicine (1)
Oncology (3)
Orphan Designated Drugs (7)
Other Innovation Areas (8)
Remote Patient Monitoring (1)
Renewable Energy (1)
Robotics (1)
Smart Hospitals (3)
Social Responsibility (6)
Virtual Care (3)
Showing 4 results out of 4
Q4 2023 update: mentions of COVID-19 in pharmaceutical industry filings
The global pharmaceutical industry experienced a 69% drop in company filings mentions of COVID-19 in Q4 2023 compared with the...
Q4 2023 update: COVID-19 related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that COVID-19 accounted for 2 pharmaceutical deals announced in Q4 2023,...
Q3 2023 update: COVID-19 related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that COVID-19 accounted for 2 pharmaceutical deals announced in Q3 2023,...
Q3 2023 update: mentions of COVID-19 in pharmaceutical industry filings
The global pharmaceutical industry experienced a 73% drop in company filings mentions of COVID-19 in Q3 2023 compared with the...